nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—RXRB—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.0546	0.165	CbGpPWpGaD
Adapalene—Abrasion NOS—Formoterol—chronic obstructive pulmonary disease	0.0517	0.0833	CcSEcCtD
Adapalene—Abrasion NOS—Arformoterol—chronic obstructive pulmonary disease	0.0517	0.0833	CcSEcCtD
Adapalene—Sensation of warmth—Salbutamol—chronic obstructive pulmonary disease	0.0297	0.0479	CcSEcCtD
Adapalene—RXRA—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.0284	0.0862	CbGpPWpGaD
Adapalene—Excoriation—Arformoterol—chronic obstructive pulmonary disease	0.0281	0.0452	CcSEcCtD
Adapalene—Excoriation—Formoterol—chronic obstructive pulmonary disease	0.0281	0.0452	CcSEcCtD
Adapalene—Eyelid oedema—Formoterol—chronic obstructive pulmonary disease	0.0168	0.0271	CcSEcCtD
Adapalene—Eyelid oedema—Arformoterol—chronic obstructive pulmonary disease	0.0168	0.0271	CcSEcCtD
Adapalene—Papilloedema—Prednisolone—chronic obstructive pulmonary disease	0.0144	0.0233	CcSEcCtD
Adapalene—Dermatitis atopic—Montelukast—chronic obstructive pulmonary disease	0.0112	0.0181	CcSEcCtD
Adapalene—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.011	0.0177	CcSEcCtD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.0108	0.0328	CbGpPWpGaD
Adapalene—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.0106	0.0171	CcSEcCtD
Adapalene—Papilloedema—Prednisone—chronic obstructive pulmonary disease	0.0105	0.0169	CcSEcCtD
Adapalene—Feeling hot—Salbutamol—chronic obstructive pulmonary disease	0.0102	0.0164	CcSEcCtD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00971	0.0294	CbGpPWpGaD
Adapalene—Skin discolouration—Arformoterol—chronic obstructive pulmonary disease	0.00939	0.0151	CcSEcCtD
Adapalene—Skin discolouration—Formoterol—chronic obstructive pulmonary disease	0.00939	0.0151	CcSEcCtD
Adapalene—RARB—respiratory system—chronic obstructive pulmonary disease	0.00937	0.19	CbGeAlD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00931	0.0282	CbGpPWpGaD
Adapalene—Herpes simplex—Arformoterol—chronic obstructive pulmonary disease	0.00921	0.0148	CcSEcCtD
Adapalene—Herpes simplex—Formoterol—chronic obstructive pulmonary disease	0.00921	0.0148	CcSEcCtD
Adapalene—Herpes simplex—Salbutamol—chronic obstructive pulmonary disease	0.00869	0.014	CcSEcCtD
Adapalene—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00858	0.0138	CcSEcCtD
Adapalene—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.00838	0.0135	CcSEcCtD
Adapalene—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.00838	0.0135	CcSEcCtD
Adapalene—RARB—bronchus—chronic obstructive pulmonary disease	0.00771	0.156	CbGeAlD
Adapalene—RARG—respiratory system—chronic obstructive pulmonary disease	0.00764	0.155	CbGeAlD
Adapalene—Optic neuritis—Prednisolone—chronic obstructive pulmonary disease	0.00747	0.012	CcSEcCtD
Adapalene—RARA—respiratory system—chronic obstructive pulmonary disease	0.00719	0.146	CbGeAlD
Adapalene—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.00708	0.0114	CcSEcCtD
Adapalene—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00699	0.0113	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00698	0.0212	CbGpPWpGaD
Adapalene—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00671	0.0108	CcSEcCtD
Adapalene—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00668	0.0108	CcSEcCtD
Adapalene—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.00647	0.0104	CcSEcCtD
Adapalene—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.00621	0.01	CcSEcCtD
Adapalene—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CTGF—chronic obstructive pulmonary disease	0.00598	0.0181	CbGpPWpGaD
Adapalene—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00567	0.00913	CcSEcCtD
Adapalene—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00564	0.00909	CcSEcCtD
Adapalene—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00564	0.00909	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—ERBB3—chronic obstructive pulmonary disease	0.00558	0.0169	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00553	0.0168	CbGpPWpGaD
Adapalene—Optic neuritis—Prednisone—chronic obstructive pulmonary disease	0.00543	0.00874	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.0053	0.0161	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—ERBB3—chronic obstructive pulmonary disease	0.00524	0.0159	CbGpPWpGaD
Adapalene—Herpes simplex—Prednisolone—chronic obstructive pulmonary disease	0.00499	0.00803	CcSEcCtD
Adapalene—RARB—lung—chronic obstructive pulmonary disease	0.00497	0.101	CbGeAlD
Adapalene—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00474	0.00763	CcSEcCtD
Adapalene—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00461	0.00743	CcSEcCtD
Adapalene—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00461	0.00743	CcSEcCtD
Adapalene—RXRB—lung—chronic obstructive pulmonary disease	0.00457	0.0927	CbGeAlD
Adapalene—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00452	0.00728	CcSEcCtD
Adapalene—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.00451	0.00727	CcSEcCtD
Adapalene—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00439	0.00708	CcSEcCtD
Adapalene—RXRA—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00438	0.0133	CbGpPWpGaD
Adapalene—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00436	0.00702	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.00433	0.0131	CbGpPWpGaD
Adapalene—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00422	0.0068	CcSEcCtD
Adapalene—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.0042	0.00676	CcSEcCtD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00419	0.0127	CbGpPWpGaD
Adapalene—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00417	0.00672	CcSEcCtD
Adapalene—RARG—lung—chronic obstructive pulmonary disease	0.00406	0.0823	CbGeAlD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00391	0.0119	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00383	0.0116	CbGpPWpGaD
Adapalene—RARA—lung—chronic obstructive pulmonary disease	0.00382	0.0774	CbGeAlD
Adapalene—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00376	0.00606	CcSEcCtD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00376	0.0114	CbGpPWpGaD
Adapalene—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00376	0.00605	CcSEcCtD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.0036	0.0109	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.0036	0.0109	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00358	0.0109	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00351	0.0106	CbGpPWpGaD
Adapalene—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00349	0.00562	CcSEcCtD
Adapalene—RXRG—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00344	0.0104	CbGpPWpGaD
Adapalene—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00339	0.00546	CcSEcCtD
Adapalene—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00339	0.00546	CcSEcCtD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00337	0.0102	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00337	0.0102	CbGpPWpGaD
Adapalene—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00332	0.00535	CcSEcCtD
Adapalene—RARA—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00323	0.0098	CbGpPWpGaD
Adapalene—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.0032	0.00515	CcSEcCtD
Adapalene—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00319	0.00513	CcSEcCtD
Adapalene—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00316	0.00509	CcSEcCtD
Adapalene—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00315	0.00507	CcSEcCtD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00308	0.00934	CbGpPWpGaD
Adapalene—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00306	0.00492	CcSEcCtD
Adapalene—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00298	0.0048	CcSEcCtD
Adapalene—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00293	0.00472	CcSEcCtD
Adapalene—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00281	0.00453	CcSEcCtD
Adapalene—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00276	0.00445	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00276	0.00837	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00276	0.00837	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—ERBB3—chronic obstructive pulmonary disease	0.00273	0.00828	CbGpPWpGaD
Adapalene—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00265	0.00427	CcSEcCtD
Adapalene—Pain—Formoterol—chronic obstructive pulmonary disease	0.00259	0.00417	CcSEcCtD
Adapalene—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00259	0.00417	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—chronic obstructive pulmonary disease	0.00256	0.00776	CbGpPWpGaD
Adapalene—Pain—Montelukast—chronic obstructive pulmonary disease	0.00254	0.00408	CcSEcCtD
Adapalene—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00251	0.00404	CcSEcCtD
Adapalene—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00251	0.00404	CcSEcCtD
Adapalene—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.0025	0.00402	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.0025	0.00757	CbGpPWpGaD
Adapalene—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00394	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.00242	0.00735	CbGpPWpGaD
Adapalene—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.0024	0.00387	CcSEcCtD
Adapalene—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.0024	0.00387	CcSEcCtD
Adapalene—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00381	CcSEcCtD
Adapalene—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00381	CcSEcCtD
Adapalene—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00236	0.00379	CcSEcCtD
Adapalene—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00234	0.00377	CcSEcCtD
Adapalene—RXRA—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.00229	0.00694	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.00228	0.00691	CbGpPWpGaD
Adapalene—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00366	CcSEcCtD
Adapalene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	0.00224	0.0068	CbGpPWpGaD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00224	0.00678	CbGpPWpGaD
Adapalene—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00359	CcSEcCtD
Adapalene—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00359	CcSEcCtD
Adapalene—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00222	0.00358	CcSEcCtD
Adapalene—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00352	CcSEcCtD
Adapalene—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00345	CcSEcCtD
Adapalene—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00345	CcSEcCtD
Adapalene—RXRG—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.00214	0.00647	CbGpPWpGaD
Adapalene—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00339	CcSEcCtD
Adapalene—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.0021	0.00338	CcSEcCtD
Adapalene—RXRA—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00206	0.00624	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00203	0.00616	CbGpPWpGaD
Adapalene—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00326	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00201	0.00611	CbGpPWpGaD
Adapalene—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00201	0.00324	CcSEcCtD
Adapalene—RARA—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.00201	0.00609	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.002	0.00608	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00197	0.00596	CbGpPWpGaD
Adapalene—Rash—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00307	CcSEcCtD
Adapalene—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00307	CcSEcCtD
Adapalene—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00307	CcSEcCtD
Adapalene—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00307	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00188	0.00569	CbGpPWpGaD
Adapalene—Rash—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00301	CcSEcCtD
Adapalene—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00301	CcSEcCtD
Adapalene—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00184	0.00296	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00181	0.0055	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00181	0.00549	CbGpPWpGaD
Adapalene—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.0029	CcSEcCtD
Adapalene—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.0029	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.0018	0.00545	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00175	0.00532	CbGpPWpGaD
Adapalene—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00174	0.0028	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.0017	0.00517	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00168	0.00511	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.00168	0.00508	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00167	0.00507	CbGpPWpGaD
Adapalene—RXRA—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.00163	0.00495	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.00162	0.0049	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0016	0.00484	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—chronic obstructive pulmonary disease	0.00159	0.00482	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00158	0.00478	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.00158	0.00478	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00147	0.00445	CbGpPWpGaD
Adapalene—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00235	CcSEcCtD
Adapalene—Pain—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.00226	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00139	0.00421	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00138	0.00418	CbGpPWpGaD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.00135	0.00409	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00134	0.00407	CbGpPWpGaD
Adapalene—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00215	CcSEcCtD
Adapalene—RXRA—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00133	0.00402	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00132	0.00399	CbGpPWpGaD
Adapalene—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.0021	CcSEcCtD
Adapalene—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00204	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00126	0.00383	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00126	0.00383	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.00126	0.00382	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00124	0.00377	CbGpPWpGaD
Adapalene—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00195	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.00119	0.0036	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.00116	0.00351	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00112	0.0034	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00111	0.00335	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.00106	0.00321	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.00105	0.00317	CbGpPWpGaD
Adapalene—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00166	CcSEcCtD
Adapalene—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00166	CcSEcCtD
Adapalene—RXRA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00102	0.00308	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000995	0.00302	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000988	0.00299	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000964	0.00292	CbGpPWpGaD
Adapalene—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000946	0.00152	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000929	0.00282	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000929	0.00282	CbGpPWpGaD
Adapalene—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000878	0.00141	CcSEcCtD
Adapalene—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000843	0.00136	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000831	0.00252	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000821	0.00249	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000797	0.00242	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000797	0.00241	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000788	0.00239	CbGpPWpGaD
Adapalene—RXRA—Metabolism—APIP—chronic obstructive pulmonary disease	0.000775	0.00235	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000763	0.00231	CbGpPWpGaD
Adapalene—Rash—Prednisone—chronic obstructive pulmonary disease	0.000751	0.00121	CcSEcCtD
Adapalene—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00075	0.00121	CcSEcCtD
Adapalene—RARA—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000749	0.00227	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000748	0.00227	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000736	0.00223	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000731	0.00222	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000717	0.00217	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000712	0.00216	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000706	0.00214	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000683	0.00207	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000669	0.00203	CbGpPWpGaD
Adapalene—RARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000658	0.002	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000658	0.00199	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000646	0.00196	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000634	0.00192	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000628	0.0019	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000612	0.00185	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000607	0.00184	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000607	0.00184	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000602	0.00183	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000602	0.00182	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.0006	0.00182	CbGpPWpGaD
Adapalene—RARB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.00059	0.00179	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000579	0.00176	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000575	0.00174	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000575	0.00174	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000566	0.00172	CbGpPWpGaD
Adapalene—RARA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000566	0.00172	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000553	0.00168	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000518	0.00157	CbGpPWpGaD
Adapalene—RXRA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000514	0.00156	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000509	0.00154	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GC—chronic obstructive pulmonary disease	0.0005	0.00151	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000484	0.00147	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000472	0.00143	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000464	0.00141	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000415	0.00126	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000398	0.00121	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000391	0.00118	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000381	0.00116	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000374	0.00113	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00037	0.00112	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.00036	0.00109	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000356	0.00108	CbGpPWpGaD
Adapalene—RARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000322	0.000976	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000317	0.00096	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000314	0.000951	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.0003	0.000909	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000295	0.000894	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000295	0.000893	CbGpPWpGaD
Adapalene—RARB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000289	0.000876	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000277	0.00084	CbGpPWpGaD
Adapalene—RARA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000277	0.00084	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000273	0.000827	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00027	0.000818	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000252	0.000763	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000246	0.000746	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000239	0.000725	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000227	0.000688	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000216	0.000655	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000194	0.000588	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000189	0.000573	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000187	0.000566	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000178	0.00054	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000175	0.00053	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000174	0.000527	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000166	0.000504	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.0005	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000144	0.000438	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.000134	0.000407	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALB—chronic obstructive pulmonary disease	0.000112	0.00034	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000107	0.000325	CbGpPWpGaD
